FdaApplication
BLA 761054
Identifiers
- fda_app_no: BLA761054
Properties
| Property | Value |
|---|---|
| applicant_name | Samsung Bioepis Co., Ltd. |
| application_type | BLA |
| approval_date | 2017-04-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RENFLEXIS | INFLIXIMAB-ABDA | 100MG | For Injection |
1 product